NanoPharmaceuticals
New York
About NanoPharmaceuticals
Developing targeted therapeutics for cancer, inflammatory disorders, and angio-proliferative diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $6.6M
- Last round: Series Unknown (Feb 2025)
- Website: nanopharmaceuticals.com
- Phone: 518-535-0800
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/nanopharmaceuticals-133313 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.